CHOP Chemotherapy plus Rituximab Compare
✍
Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv
📂
Article
📅
2002
🏛
Massachusetts Medical Society
🌐
English
⚖ 116 KB
## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct